Fig. 5

Flow cytometric analysis charts of CD46 and CD55 in healthy controls and acute leukemia patients’ peripheral blood samples. Flow cytometric analysis of the protein expression level of both CD46 and CD55 in the peripheral blood samples of acute leukemia patients showed a significant reduction in both proteins compared to healthy controls. Results shown are from a representative experiment. (A) CD46 expression in a healthy control. (B) CD46 expression in an AML patient. (C) CD46 expression in an ALL patient. (D) CD55 expression in a healthy control. (E) CD55 expression in an AML patient. (F) CD55 expression in an ALL patient.